Equities

Cell MedX Corp

CMXC:PKC

Cell MedX Corp

Actions
  • Price (USD)0.0223
  • Today's Change0.001 / 6.19%
  • Shares traded1.30k
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of May 20 2024 14:30 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Cell MedX Corp. is a biotechnology company. It is focused on the discovery, development and commercialization of therapeutic and non-therapeutic products that promote general wellness, general health, pain relief, wellness and alleviate complications associated with medical conditions including, diabetes, Parkinson’s disease, high blood pressure, neuropathy, and kidney function. The Company, through its subsidiary, is engaged in developing and manufacturing therapeutic devices based on its eBalance technology, which harnesses the power of microcurrents and its effects on the human body. The eBalance Pro System and eBalance Home System, are microcurrent electrotherapy systems intended to administer a specific variety of therapeutic microcurrent algorithms for temporary relief of pain associated with sore/aching muscles in the shoulders, waist, back, neck, upper extremities (arms) and lower extremities. Its Microcurrent therapy uses molecular bioelectricity in cell-to-cell signaling.

  • Revenue in USD (TTM)70.00
  • Net income in USD-96.91k
  • Incorporated2010
  • Employees0.00
  • Location
    Cell MedX Corp123 W. Nye Ln, Suite 446CARSON CITY 89706United StatesUSA
  • Phone+1 (310) 508-9398
  • Fax+1 (775) 884-9383
  • Websitehttps://cellmedx.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Healthy Extracts Inc2.49m-2.47m5.93m----6.19--2.38-0.8588-0.85880.86110.32310.9180.492136.50---91.32-53.78-174.02-146.6565.9045.68-99.48-87.530.1636-9.720.5245--10.41105.93-151.54------
Palisade Bio Inc0.00-13.49m5.96m9.00--0.5381-----24.67-24.670.0011.820.00----0.00-96.63-132.36-111.78-165.45-------27,892.32---874.310.00-----0.781413.74--18.53--
Glucose Health Inc1.11m-456.46k5.97m2.00--6.30--5.37-0.033-0.0330.08030.0561-----------86.94---153.9547.1940.68-31.99-56.93313.11--0.00--98.3924.9416.87------
Creative Medical Technology Holdings Inc9.00k-5.28m6.04m4.00--0.6532--670.78-3.74-3.740.00646.810.00070.4291--2,250.00-42.47-110.00-43.88--60.0065.82-58,624.33-7,961.1423.53--0.00---89.84-40.8647.88------
Shineco Inc4.50m-13.99m6.16m87.00--0.0158--1.37-3.93-4.630.443160.930.05580.39320.984451,761.38-18.99-12.77-34.44-16.8411.9425.88-340.48-102.060.4903-9.040.3792-----58.35-33.86------
Soligenix Inc839.36k-6.14m6.20m13.00--1.62--7.39-0.9164-0.91640.10850.2430.0697--5.8664,566.15-51.01-75.40-872.23-154.3211.5922.83-731.60-620.02---1,677.110.5639---11.54-30.6755.50------
Cannabis Bioscience Internatnl Hlgs Inc56.94m6.94m6.23m389.000.00110.00010.67520.10940.53280.53284.294.920.591762.811.45146,384.307.83--11.73--31.96--13.24--0.685650.750.0631--12.79--177.84------
Cell MedX Corp70.00-96.91k6.24m0.00------89,170.91-0.0029-0.00290.00-0.00240.0015-------202.28-792.55-----685.71---138,442.90-3,681.84---3.17-----54.53--29.01------
Reliv International Inc35.13m-175.48k6.35m208.00--0.916515.880.1808-0.1005-0.100520.126.552.098.02228.49---1.05-4.65-1.47-6.0640.9041.98-0.4996-2.331.07--0.1064---2.94-9.3776.65---35.85--
Theriva Biologics Inc0.00-19.04m6.40m21.00--0.2025-----1.15-1.150.001.990.00----0.00-32.65-36.95-37.33-40.16------------0.0064------8.37--95.91--
Paranovus Entertainment Technology Ltd51.46m-42.62m6.46m80.00--0.6048--0.1255-7.16-7.499.891.461.1859.614.15643,209.90-91.12-23.19-119.36-27.214.9223.09-77.15-24.253.97-2,465.220.00--9.689.80-45.84---21.93--
NLS Pharmaceutics AG0.00-15.47m6.49m2.00---------0.534-0.5340.00-0.13220.00----0.00-714.74-308.05---------------175.42---------38.08------
Enveric Biosciences Inc0.00-17.46m6.51m7.00--1.18-----8.15-8.150.000.71420.00----0.00-144.99-104.94-207.98-156.88-------243.54----0.00------7.14------
Ainos Inc122.11k-13.77m6.54m46.00--0.199--53.52-3.32-3.320.02985.230.00350.98541.212,654.57-39.94-36.36-42.28-58.33-207.8036.82-11,277.18-813.631.72-91.590.1961---96.539.461.69--66.44--
Data as of May 20 2024. Currency figures normalised to Cell MedX Corp's reporting currency: US Dollar USD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.